Incidence of Diffuse Large B-Cell Lymphoma of Germinal Center B-Cell Origin in Whole Diffuse Large B-Cell Lymphoma: Tissue Fluorescence In Situ Hybridization Using t(14;18) Compared with Immunohistochemistry
Authors:
- 1 January 2005
- journal article
- Published by Springer Nature in International Journal of Hematology
- Vol. 81 (1) , 48-57
Abstract
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important categories such as germinal center B (GCB)-like and non-GCB-like groups. The t(14;18)(q32;q21) translocation defines a unique subset of DLBCL cases with a GCB gene expression profile. Two-color fluorescence in situ hybridization (FISH) analysis was applied to detect t(14;18) (q32;q21) in the nuclei of paraffin-embedded tissue sections from 61 patients with de novo DLBCL.Nine (15%) of 61 cases had a positive pattern. Fifty-seven cases were subclassified in an immunohistochemical study with anti-CD10, anti-bcl-6, and anti-MUM1 antibodies. In this classification, 21 cases (37%) were placed in the GCB group, and 36 (63%) were placed in the non-GCB group. There was a discrepancy between t(14;18) occurrence and bcl-2 protein expression. Bcl-2 protein expression was positive in 40 (67%) of 60 cases.The expression of bcl-2 protein in the GCB and non-GCB groups was not significantly different: 15 (71%) of 21 cases in the GCB group and 24 (67%) of 36 cases in the non-GCB group tested positive.We found no difference between the FISH-positive and FISH-negative groups in overall survival time (P = .6019, log-rank test).The overall survival rates of GCB and non-GCB groups did not differ significantly by immunohistochemical classification (P = .5399, log-rank test). Overall survival was significantly longer in the group with a low International Prognostic Index (IPI) score than in the group with a high IPI score (P = .0002, log-rank test).Our results suggest that immunohistochemical study and cytogenetic study with t(14;18) FISH cannot predict the clinical outcomes of DLBCL patients.Astudy with a larger number of patients may show a difference in clinical outcomes between FISH-positive and FISH-negative groups and between GCB and non-GCB groups.Keywords
This publication has 28 references indexed in Scilit:
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell featuresBlood, 2003
- Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Blood, 2003
- Tissue Micro-Array: A Cost and Time-Effective Method for Correlative Studies by Regional and National Cancer Study GroupsLaboratory Investigation, 2002
- Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and ImmunohistochemistryLaboratory Investigation, 2001
- Recurring chromosomal abnormalities in non-hodgkin's lymphoma: Biologic and clinical significanceSeminars in Hematology, 2000
- The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entitiesPathology International, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomasGenes, Chromosomes and Cancer, 1999
- bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell LymphomaNew England Journal of Medicine, 1989